GNFTF OTC
Genfit S.a.
1W: +0.0%
1M: +0.0%
3M: +46.5%
YTD: +162.5%
1Y: +323.4%
3Y: -1.9%
5Y: -52.4%
$15.75
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$789.0M
52W Range3.72-16.5
Volume500
Avg Volume24
Beta1.14
Dividend—
Analyst Ratings
Company Info
CEOPascal Prigent
Employees161
SectorHealthcare
IndustryBiotechnology
IPO Date2014-01-27
Websitegenfit.com
Parc EurasantE
Loos, HF 59120
FR
Loos, HF 59120
FR
33 3 20 16 40 00
About Genfit S.a.
Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company focuses on the discovery and development of drug candidates in areas of high unmet medical needs corresponding to a lack of suitable treatments. It focuses on medicines to market for patients with metabolic, inflammatory, autoimmune and fibrotic diseases that affect the liver. The company was founded by Jean-François Mouney, Florence Séjourné, and Bart Staels in September 1999 and is headquartered in Loos, France.
Latest News
No recent news
Recent Insider Trades
No insider trades found